An official website of the United States government Here's how you know

U.S. Department of Health and Human Services | National Institutes of Health

Official websites use .gov
A .gov website belongs to an official government
organization in the United States.

Secure .gov websites use HTTPS
A lock (🔒) or https:// means you've safely connected to the .gov website.
Share sensitive information only on official, secure websites.

PAR-21-033 - National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Title	Notice Number	Organization	Release Date	Expiration Date	Activity Code(s)
Notice of Special Interest (NOSI): Accelerating Progress in Celiac Disease Research	NOT-AI-22-004	NIAID, NIAMS, NCCIH, NCI	Nov 23, 2021	Jan 8, 2025	R03, R21, U01, U44, R01, R34, P01, R61/R33
Notice of Special Interest (NOSI): Developing and Testing Multilevel Physical Activity Interventions to Improve Health and Well-Being	NOT-OD-21-087	ODP, NCCIH, NCI, NIA, NIAAA, NIAMS, NICHD, NIDCD, NIMH, NIMHD, NINR, OBSSR, ORWH	Apr 6, 2021	Feb 16, 2024	R01, R21, 333, R03

For technical issues E-mail OER Webmaster

Redirect Notice

PAR-21-033 - National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required) is used for the submission of applications to the following Notices of Special Interest (NOSIs)

Expired NOSIs

Stay Connected

Government Sites

Web Policies and Notices

Site Map